SAFYBI (Sociedad Argentina de Farmacia y Bioquímica Industrial) is organizing the course “Updates on Bioequivalence Studies”, to be held on August 5, 12, 19 and 26, 2026, from 6:00 to 9:00 PM, in synchronous online format, with a total of 12 hours and a certificate with evaluation.
The course offers an updated, critical view of bioequivalence studies for the development of generic and multisource medicines in Argentina and LATAM: current regulations, biowaivers, the latest international trends, virtual bioequivalence, and the new FDA guidelines.
We are proud that our Director, Dr. Ethel Feleder, is among the speakers, alongside Dr. Carolina Sian (Course Director), Dr. Sofía Helena Harriet, Dr. Fernando Costa, and Dr. María Sylvia Viola (Coordinator).
SAFYBI members receive a 50% discount on registration.
More information and registration (SAFYBI)On 01/20/2026, ANMAT Salud published Disposition 47/2026 in the Official Gazette, updating the list of APIs that must undergo bioequivalence/bioavailability studies.
Read moreDr. Ethel Feleder, our Director, was selected by ANMAT to join the Network of Experts in Pharmacological Clinical Research.
Read more
